Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

In the U.S, it is estimated that some 1.1 million people are living with Parkinson's disease—a figure only expected to rise in the near future, according to the Parkinson's Foundation.

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

SYDNEY, June 27 (Xinhua) -- Scientists have achieved a major breakthrough in Parkinson's disease research, identifying a brain protein that may unlock new possibilities for treatment, a new ...

R09b, for the treatment of Primary Parkinson’s Disease (PD), has received Fast Track Designation (FTD) from the U.S. Food and ...